Overview: LANTUS SOLOSTAR is a pharmaceutical product containing insulin glargine, manufactured by Sanofi. It is presented in the form of disposable pre-filled pens, each containing 300 IU of insulin glargine solution. This medication is primarily used for the management of diabetes mellitus.
Detailed Description:
1. Active Substance: LANTUS SOLOSTAR contains insulin glargine, a long-acting basal insulin analogue. It mimics the action of naturally produced insulin, providing a steady level of insulin activity over an extended period.
2. Form and Packaging: Each pack of LANTUS SOLOSTAR includes 5 disposable pre-filled pens, each pen containing 300 IU (10 mL) of insulin glargine solution. The pens are designed for convenient and accurate dosing, making them suitable for self-administration by patients.
3. Indications: LANTUS SOLOSTAR is indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and older. It is used to maintain basal insulin levels throughout the day and night to help control blood sugar levels.
4. Administration: The insulin glargine in LANTUS SOLOSTAR is administered via subcutaneous injection. The pen is designed for easy handling and precise dosing, allowing patients to adjust their insulin doses as prescribed by their healthcare provider.
5. Storage: Prior to first use, LANTUS SOLOSTAR should be stored in the refrigerator between 36°F to 46°F (2°C to 8°C). Once in use, the pen in use can be kept at room temperature (below 86°F or 30°C) for up to 28 days, after which it should be discarded, even if there is insulin left in the pen.
6. Precautions and Warnings:
- Patients using LANTUS SOLOSTAR should monitor their blood glucose levels regularly and adjust their insulin dose as directed by their healthcare provider.
- Hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) may occur with insulin therapy. Patients should be educated on recognizing and managing these conditions.
- Patients with known hypersensitivity to insulin glargine or any of the product’s components should not use LANTUS SOLOSTAR.
7. Adverse Reactions: Common side effects may include hypoglycemia, injection site reactions (such as redness, swelling, or itching), weight gain, and allergic reactions. Patients should report any unexpected or severe reactions to their healthcare provider.
8. Manufacturer: LANTUS SOLOSTAR is manufactured by Sanofi, a leading global healthcare company known for its dedication to producing innovative medications and therapies.
Reviews
There are no reviews yet.